Skip to content

CARDIO INVEST

Active
Private limited companyfounded 2025active for 1 yearMoorselbaan 164, 9300 Aalst, BelgiumKBO/BCE: BE 1018.122.292
Summary

CARDIO INVEST has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€638) and a net result of -€1,388. The computed 12-month bankruptcy probability is 1.3% (low).

Overview

Official details

Source: KBO
Status
Active since 02-01-2025 Normal situation
Registered office
89 active companies are registered at this address 2 started in the 12 months before. Source: KBO register, as of 3 November 2026.
Activity
“Het verrichten van alle consultancyopdrachten en logistieke ondersteuning in verband met wetenschappelijk onderzoek en…” (deed in Dutch)From the articles, 8 activitiesNo NACE code in the KBO yet
Establishment unit
2.369.892.419 9300 Aalst, since 02-01-2025
Financial year end
31 December
Peppol
Reachable since 14-10-2026

Board and ownership

Board
and 2 others
Auditor
Filip Cobert Bedrijfsrevisor
Shareholders

Financial position

53 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
1.3%
Annual accounts 2025
Gross margin
-€1,388
Loss
€1,388
Equity
-€638
Total assets
€4,362
  • Negative equity on 31-12-2025
Turnover not published (micro format)
Score breakdownraises riskCapped at 59: negative equityNo main activity registeredFounded in 2025lowers riskSize: total assets €4,362Liquidity: current ratio 0.72, cash €3,612Show the evidence

Checked score

Score 2025
53 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 17% of micro companies without a NACE code
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength
Weak
Solvency 10
equity -14.6% of total assets
Liquidity 50
short-term debt 114.6% · cash 82.8%
Profitability 0
return on assets -31.8%
Bankruptcy probability within 12 months
1.3% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 02-2026: 2.4% 03-2026: 2.5%▲ +0.1 percentage points vs 02-2026 04-2026: 2.9%▲ +0.4 percentage points vs 03-2026 05-2026: 3.1%▲ +0.2 percentage points vs 04-2026 06-2026: 3.4%▲ +0.3 percentage points vs 05-2026 07-2026: 3.4%● unchanged vs 06-2026 08-2026: 3.6%▲ +0.2 percentage points vs 07-2026highest value 09-2026: 3.6%● unchanged vs 08-2026 10-2026: 1.3%▼ -2.3 percentage points vs 09-2026lowest value 11-2026: 1.3%● unchanged vs 10-2026lowest value
No credit on open account
The balance sheet total is too small for a liquidity verdict. Equity is negative.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 11% of them on solvency, 35% on liquidity and 4% on profitability.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €4,362
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.72, cash €3,612
NBB · annual accounts
raises risk · No main activity registered
KBO
raises risk · Founded in 2025
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
31 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2025.
KBO publications

Key points

  • Risk: Negative equitydebts exceed assets in financial year 2025 -€638 View
  • Branch taken over from CARDIAC RESEARCH INSTITUTEtakeover on 13-01-2025 2025 View

Recent changes

  1. · Gazette deed IncorporationStarting capital €750 · Demerger: CARDIAC RESEARCH INSTITUTE splits off to CARDIO INVEST · Appointments: FILIP COBERT BEDRIJFSREVISOR, Dicentra and 4 others · Permanent representatives: Jozef Bartúnek, Tom De Potter and 3 others
All 2 events

Key facts about CARDIO INVEST

What is the company number of CARDIO INVEST?
The company number of CARDIO INVEST is 1018.122.292. The VAT number is the same number with BE in front: BE 1018.122.292.
Where is CARDIO INVEST based?
The registered office is at Moorselbaan 164, 9300 Aalst.Company details
What is the legal form of CARDIO INVEST?
The legal form of CARDIO INVEST is Private limited company (BV).
When was CARDIO INVEST founded?
CARDIO INVEST was founded on 02-01-2025.
Is CARDIO INVEST still active?
Yes, CARDIO INVEST is an active enterprise in the KBO register.
What is the turnover of CARDIO INVEST?
The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
Is CARDIO INVEST profitable?
In financial year 2025, CARDIO INVEST made a loss of €1,388.
Where can I find the annual accounts of CARDIO INVEST?
CARDIO INVEST filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.